Eleven companies in Ontario, including Novel Biotechnology in Vaughan, will each receive $500,000 to help commercialize their technologies. This investment is part of the province’s $15 million Life Sciences Innovation Fund (LSIF), which was created in 2022 to help entrepreneurs and innovators bring their ideas and prototypes from the lab to the marketplace.
Full Article: news.ontario.ca